|
|
Elderly Fall Rate Cut by 96% in Neuropathy Study using Anodyne Therapy
|
Added: 04/01/2004
Type: Summary
Viewed: 998 time(s)
[ Not Rated Yet ] |
Elderly Fall Rate Cut by 96% in Neuropathy Study using Anodyne Therapy
Anodyne Therapy, LLC today announced the publication of a fourth peer-reviewed clinical study demonstrating restoration of sensation in the feet of patients with peripheral neuropathy. Also, these patients obtained significant improvements in ambulation and balance, which led to a 96% reduction in fall rates. This study, conducted at Aurora Medical Center in Denver, Colorado by Alan Kochman, MSPT, appears in the April 2004 issue of Geriatric Physical Therapy.
Previous studies have shown that sensory impairments due to peripheral neuropathy present a significant independent risk for falls that could not be adequately addressed because of the lack of a treatment intervention for the underlying peripheral neuropathy. Prior to receiving Anodyne treatments, the patients with peripheral neuropathy in this study were at high risk for falls based on standardized testing of balance and gait and had experienced an average of 3 falls during preceding 90 days. After obtaining improved foot sensation through the use of Anodyne treatments, all patients obtained remarkable increases in ambulation and balance as well as significant reductions in their fall risk. Actual falls during the 90 days after treatment, decreased by 96%.
“We are thrilled with the publication of this additional study in Geriatric Physical Therapy, especially in light of the reported improvements in ambulation and reduction of elderly falls,” said Craig Turtzo, CEO. “One of our previously reported studies had shown significant improvements in balance when patients with peripheral neuropathy obtained treatments with Anodyne, but the benefits to the patients in this study exceeded our expectations. Other investigators are examining the extent by which Anodyne treatments will reduce the incidence of diabetic foot wounds, another serious complication of peripheral neuropathy. We expect to soon report decreases in diabetic foot wounds in addition to reductions in elderly falls that were reported in this study.” Added Mr. Turtzo, “It is very gratifying to be able to improve the lives of patients with peripheral neuropathy, who prior to Anodyne, did not have access to viable treatment options for their condition. Additionally, it appears that we can help drive down the medical costs normally associated with peripheral neuropathy, which have been estimated to exceed $37 billion per year among people with diabetes alone.”
Anodyne Therapy treatments are currently available nationwide at more than a thousand outpatient therapy facilities, hospitals, nursing homes, physician offices and home health agencies to improve functional outcomes for patients suffering from peripheral neuropathy, chronic pain and a broad range of other health problems. Products are also available for convenient home use. For more information, visit www.anodynetherapy.com.
Contact Information:
Kim Stebbings
Vice President, Sales and Marketing
Anodyne Therapy, LLC
13570 Wright Circle
Tampa, FL 33626
Office: 813-342-4432 ext. 122
Cell: 720-560-0533
Email: kimstebbings@aol.com
|
Article Pages: 1
Article Comments
 Add Comment |
 View All (0)
There are currently no comments for this article.
|
|
|
Good Resources